Estrogen Plus Progestin Vs

1. The relative risk of probable dementia for estrogen plus progestin vs.

Placebo Groups

1. The most common classification of probable dementia in the estrogen plus progestin and placebo groups was Alzheimer's disease. (Web site)

Result

1. Taking HT as a combination therapy — estrogen plus progestin — can result in serious health risks.

Colorectal

1. Chlebowski RT, Wactawski-Wende J, Ritenbaugh C, et al.: Estrogen plus progestin and colorectal cancer in postmenopausal women.

Healthy Postmenopausal Women

1. Risks and benefits of estrogen plus progestin in healthy postmenopausal women. (Web site)

Conclusions

1. CONCLUSIONS: In postmenopausal women with hypercholesterolemia, therapy with estrogen plus progestin has beneficial effects on lipoprotein levels.

Stroke

1. An increased risk of stroke, DVT, pulmonary embolism, and myocardial infarction has been reported with estrogen plus progestin therapy. (Web site)

Women

1. The effect was similar among women who took conjugated estrogen only and among those who received estrogen plus progestin.
2. Clinical surveillance of all women using estrogen plus progestin therapy is important. (Web site)

Risk

1. In conclusion, our trial documents that estrogen plus progestin does not have a beneficial effect on the risk of CHD among healthy postmenopausal women.
2. Effects of estrogen plus progestin on risk of fracture and bone mineral density: the Women's Health Initiative randomized trial.
3. OBJECTIVE: To determine if estrogen plus progestin therapy alters the risk for CHD events in postmenopausal women with established coronary disease.

Breast

1. Long-term continuous administration of estrogen plus progestin therapy, has shown an increased risk of breast cancer and ovarian cancer. (Web site)

Coronary Heart Disease

1. Estrogen plus progestin and the risk of coronary heart disease.

Excess Risk

1. These analyses produced higher estimates of the excess risk with estrogen plus progestin.

Mammography

1. Estrogen plus progestin and breast cancer detection by means of mammography and breast biopsy. (Web site)

Estrogen

1. The use of estrogen alone and estrogen plus progestin has been reported to result in an increase in abnormal mammograms requiring further evaluation. (Web site)

Postmenopausal Women

1. Effect of estrogen plus progestin on stroke in postmenopausal women: the Women's Health Initiative.
2. Breast cancer after use of estrogen plus progestin in postmenopausal women. (Web site)
3. Randomized trial of estrogen plus progestin for secondary prevention of coronary heart disease in postmenopausal women. (Web site)

Estrogen Plus Progestin

1. CONCLUSIONS: Estrogen plus progestin increases the risk of ischemic stroke in generally healthy postmenopausal women.
2. Influence of estrogen plus progestin on breast cancer and mammography in healthy postmenopausal women: the Women's Health Initiative Randomized Trial. (Web site)
3. After a mean follow-up of 5.6 years, the WHI trial reported an increased risk of breast cancer in women who took estrogen plus progestin. (Web site)

Categories

1. Postmenopausal Women
2. Mammography
3. Excess Risk
4. Breast Biopsy
5. Estrogen
6. Books about "Estrogen Plus Progestin" in Amazon.com
   

Continue: More Keywords - - - - - - - - - -